Summer Sale Extended! Get unlimited digital access for 13 weeks for $13.
Topics

University of North Carolina at Chapel Hill

Pain relievers may factor into cancer protection

Pain relievers may factor into cancer protection

Regularly taking low-dose aspirin or other common pain relievers may lower long-term risk of colon cancer, new research suggests. Men and women who took low-dose (75 to 150 milligrams) aspirin for five years or more saw their risk of colon cancer drop by 27 percent. And taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen for that long was linked to a 30 percent to 45 percent drop in colon cancer risk, the study found. "The protective association is certainly amazing, and it's a good example of how everyday drugs can have unexpected benefits," said study co-author Dr. John Baron, a professor of medicine at the University of North Carolina School of...

Loading
77°